Over 100 Cancer Medicines See No Price Reduction Despite Trade-Margin Cap
More than 100 medicines on the NPPA’s revised pricing list have not registered a price reduction despite the Centre’s move to cap trade margins on certain oncology medicines.
More than 100 medicines on the NPPA’s revised pricing list have not registered a price reduction despite the Centre’s move to cap trade margins on certain oncology medicines.